Evidence map›Paper›PMID 32944671›Full record

ArticleAmerican journal of ophthalmology case reports2020

Ocular evaluation and genetic test for an early Alström Syndrome diagnosis.

Tyler Etheridge, Elizabeth R Kellom, Rachel Sullivan, James N Ver Hoeve, Melanie A Schmitt

Open access · goldAbstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Syndromic Retinitis Pigmentosa: A Narrative Review.Vision (Basel, Switzerland) · 2025
    Review
  2. Review
  3. Article
  4. Chromophore supply modulates cone function and survival in retinitis pigmentosa mouse models.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tyler EtheridgeUniversity of Wisconsin School of Medicine and Public Health, Department of Ophthalmology & Visual Sciences, Madison, WI, United States.
Elizabeth R KellomUniversity of Wisconsin School of Medicine and Public Health, Department of Ophthalmology & Visual Sciences, Madison, WI, United States.
Rachel SullivanUniversity of Wisconsin School of Medicine and Public Health, Department of Ophthalmology & Visual Sciences, Madison, WI, United States.
James N Ver HoeveUniversity of Wisconsin School of Medicine and Public Health, Department of Ophthalmology & Visual Sciences, Madison, WI, United States.
Melanie A SchmittUniversity of Wisconsin School of Medicine and Public Health, Department of Ophthalmology & Visual Sciences, Madison, WI, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe present 3 cases of Alström syndrome (ALMS) that highlight the importance of the ophthalmic exam, as well as the diagnostic challenges and management considerations of this ultra-rare disease. OBSERVATIONS: The first case is of a 2-year-old boy with history of spasmus nutans who presented with head bobbing and nystagmus. The second patient is a 5-year-old boy with history of infantile dilated cardiomyopathy status post heart transplant, Burkitt lymphoma status post chemotherapy, obesity, global developmental delay, and high hyperopia previously thought to have cortical visual impairment secondary to heart surgery/possible ischemic event. This patient presented with nystagmus, photophobia, and reduced vision. The third case involves a 8-year-old boy with history of obesity, bilateral optic nerve atrophy, hyperopic astigmatism, exotropia, and nystagmus. Upon presentation to the consulting pediatric ophthalmologist, none of the patients had yet been diagnosed with ALMS. All 3 cases were subsequently found to have an electroretinogram (ERG) that exhibited severe global depression and to carry CONCLUSIONS AND IMPORTANCE: ALMS is an autosomal recessive disease caused by

Indexed as

ALMS1 geneALMS, Alström SyndromeAlström syndromeAPD, Afferent pupillary defectAutosomal recessiveBMI, Body mass indexcDNA, complementary DNACHF, Congestive heart failureCLIA, Clinical Laboratory Improvement AmendmentsCone-rod dystrophyDA, Dark-adaptedDFE, Dilated fundus examEEG, ElectroencephalogramERG, ElectroretinogramEUA, Exam under anesthesiaFAF, Fundus autofluorescenceIGF, Insulin-like growth factorIR, Insulin resistanceISCEV, International Society for Clinical Electrophysiology of VisionLA, Light-adaptedMRI, Magnetic resonance imagingOCT, Optical coherence tomographyOD, Right eyeOPs, Oscillatory potentialsOS, Left eyeOU, Both eyesRPE, Retinal pigment epitheliumT2DM, Type II diabetes mellitusVA, Visual acuityVEP, Visual evoked potentialVGB, Vigabatrin

Identifiers

PMID32944671
PMCPMC7481517
OpenAlexW3048385006

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.